ehaweb.org
CHROMOSOMAL ABNORMALITIES DURING THE CLINICAL COURSE OF ADULT ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Olena Zotova, 324044
CGH ARRAYS REVEAL ADDITIONAL CLINICALLY RELEVANT CHROMOSOME ABNORMALITIES IN POSITIVE PHILADELPHIA ACUTE LIMPHOBLASTIC LEUKEMIA: A CASE STUDY
EHA Library, Alessandra Pansa, 324043
BCR-ABL P190 QUANTITATION EVALUATED BY COMMERCIALLY AVAILABLE ASSAYS AND THE CEPHEID XPERT® BCR-ABL ULTRA P190 PROTOTYPE‡ASSAY
EHA Library, Adam Aslam, 324042
DEVELOPMENT OF ASSAY CALIBRATION MEHTHODOLOGY FOR CEPHEID XPERT® BCR-ABL ULTRA P190 PROTOTYPE‡ ASSAY
EHA Library, Yuanyuan LIU, 324041
EVALUATION OF BIOMATRICA’S RNASTABLE (BRS) AND NOVEL STABILIZER (CPHD1) TO PRESERVE IVT-RNA AT ROOM TEMPERATURE(RT) TO BE USED FOR CALIBRATION OF THE CEPHEID XPERT® BCR-ABL ULTRA P190 PROTOTYPE‡ ASSAY
EHA Library, Tran Tran, 324040
PATHOGENETIC ROLE OF TUMOR NECROSIS FACTOR (TNF) AND TRANSFORMING GROWTH FACTOR Β1 (TGFΒ1) IN THE CHANGING OF ADHESIVE PROPERTIES OF VASCULAR ENDOTHELIUM (VE) IN ACUTE LEUKEMIA (AL)
EHA Library, Vira Barilka, 324039
¬HIGH FREQUENCY OF SPONTANEOUS LOSS OF HETEROZYGOSITY AND ELEVATED MICROSATELLITE ALTERATION AT SELECTED TETRANUCLEOTIDES IN LEUKEMIA CELLS STR-PROFILES: IN-VITRO TESTING OF LYMPHOBLASTOID CELL LINES
EHA Library, Natalya Risinskaya, 324038
THE ROLE OF CASPASE-8 (CASP8) AND -10 (CASP10) GENE POLYMORPHISMS IN CHILDREN AND ADOLESCENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Marilena Lourou, 324037
NRF2 AS A THERAPEUTIC TARGET IN ACUTE LEUCEMIA – IN VITRO STUDIES WITH OLTIPRAZ
EHA Library, Raquel Alves, 324036
Patient care - part 1
EHA Library, Eoin McGrath, 313555
Abstract Book 2020
EHA Library, Faculty / Presenters, 307451
Educational Updates in Hematology 2020
EHA Library, Faculty / Presenters, 307450
Metabolomics - Can we cure cancer by metabolic conditioning?
EHA Library, Vassiliki Boussiotis, 313420
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF VENETOCLAX WITH AZACITIDINE VS AZACITIDINE IN TREATMENT-NAÏVE PATIENTS WITH ACUTE MYELOID LEUKEMIA INELIGIBLE FOR INTENSIVE THERAPY-VIALE-A
EHA Library, Courtney DiNardo, 303390
PHASE II RANDOMIZED CLINICAL TRIAL COMPARING ROPEGINTERFERON VERSUS PHLEBOTOMY IN LOW-RISK PATIENTS WITH POLYCYTHEMIA VERA. RESULTS OF THE PRE-PLANNED INTERIM ANALYSIS
EHA Library, Tiziano Barbui, 303391
ISATUXIMAB PLUS CARFILZOMIB AND DEXAMETHASONE VS CARFILZOMIB AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (IKEMA): INTERIM ANALYSIS OF A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY
EHA Library, Philippe Moreau, 303392
ENDOTHELIOPATHY IS ESSENTIAL IN COVID-19 ASSOCIATED COAGULOPATHY
EHA Library, George Goshua, 303393
REAL-TIME NATIONAL SURVEY OF COVID-19 IN HEMOGLOBINOPATHY AND RARE INHERITED ANEMIA PATIENTS
EHA Library, Paul Telfer, 303394
SUBCUTANEOUS DARATUMUMAB + CYCLOPHOSPHAMIDE, BORTEZOMIB, AND DEXAMETHASONE (CYBORD) IN PATIENTS WITH NEWLY DIAGNOSED LIGHT CHAIN (AL) AMYLOIDOSIS: PRIMARY RESULTS FROM THE PHASE 3 ANDROMEDA STUDY
EHA Library, Efstathios Kastritis, 303396
Are we ready to treat high-risk patients with DLBCL differently? Relapsed/refractory disease – a continued area of unmet me
EHA Library, H Tilly, 312355
How molecular insights are changing the way we understand individual patients
EHA Library, Stefano Pileri, 312354
Interactive session: Welcome and voting on patient cases
EHA Library, Georg Hess, 312353
Can novel approaches for early response assessment guide timely clinical decisions?
EHA Library, A Schuh, 312352
Part II: Case studies, panel discussion and Q&A - From science to practice – a step closer to personalised care in NHL? - F
EHA Library, Faculty / Presenters, 312351
Are we ready to treat high-risk patients with DLBCL differently? Personalising front-line therapy – when standard treatment
EHA Library, Ulrich Jäger, 312350
Session Opening & Current landscape in the management of multiple myeloma
EHA Library, Mohamad Mohty, 312349
Future horizons for CAR T-cells, bispecifics and other advanced therapy medicinal products in multiple myeloma
EHA Library, Hermann Einsele, 312348
Panel Discussion and Q&A
EHA Library, Faculty / Presenters, 312347
What I need to know about advanced therapy medicinal products for my clinical practice – facts or fiction: An interactive d
EHA Library, Joseph Mikhael, 312346
Follicular lymphoma from genetics to the clinic
EHA Library, Gilles Salles, 313417
Summary and close
EHA Library, Ifeyinwa Osunkwo, 312336
Infectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapy
EHA Library, Marion Subklewe, 312337
Session Opening & The burden of infection in Chronic Lymphocytic Leukemia and Multiple Myeloma/COVID-19 in patients with ch
EHA Library, Tadeusz Robak, 312338
Future perspectives and closing remarks
EHA Library, Tadeusz Robak, 312339
Recommendations and consensus for the use of IgG therapy in patients with hematological malignancies and secondary immune d
EHA Library, M Albert, 312340
Panel Discussion & Closing
EHA Library, Faculty / Presenters, 312341
Focus on bispecific antibody safety: are there any new signals?
EHA Library, Martin Hutchings, 312342
Understanding the latest clinical data for bispecific antibodies and other T-cell engaging therapies in NHL
EHA Library, Sarit Assouline, 312343
What impact will CD20/CD3 bispecific antibodies have on the evolving NHL treatment landscape?
EHA Library, Franck Morschhauser, 312344
Session Opening & Zooming in on T-cell engaging therapies in NHL
EHA Library, S Dietrich, 312345
Living with SCD: Understanding the consequences
EHA Library, R Colombatti, 312334
Effective management of VOCs: Overcoming barriers and finding solutions
EHA Library, Ifeyinwa Osunkwo, 312333
Welcome and Introduction
EHA Library, Ifeyinwa Osunkwo, 312332
COVID-19 and SCD: The experts in conversation
EHA Library, Ifeyinwa Osunkwo, 312331
Toxicities in adult versus pediatric ALL patients and consequences for management
EHA Library, K Schmiegelow, 312330
Efficacy, tolerability and management strategies in the GMALL trials
EHA Library, Nicola Gökbuget, 312329
Asparaginase pharmacokinetics and pharmacodynamics
EHA Library, M Relling, 312328
Q&A
EHA Library, Faculty / Presenters, 312327
Questions and Discussion
EHA Library, Nicola Gökbuget, 312326
Q&A
EHA Library, Faculty / Presenters, 312325
Impact and treatment of SCD: Hearing the patient viewpoint
EHA Library, John James, 312335
Drug induced immune hemolytic disease: Diagnostic challenges
EHA Library, Quentin A Hill, 313435
Hydroxyurea: Fertility a still open question in adulthood
EHA Library, David Rees, 313421
Improving efficacy and persistence of CAR-T cell
EHA Library, Christian Chabannon, 313422
T-cell engaging antibodies for hematological diseases from approved therapies to new indications
EHA Library, Hermann Einsele, 313423
CAR T cells
EHA Library, Paula Rodríguez-Otero, 313424
Iron overload, monitoring and management
EHA Library, Ali T. Taher, 313425
Novel treatment options
EHA Library, Subarna Chakravorty, 313426
Real life CAR T treatment
EHA Library, Catherine Thieblemont, 313427
Epidemiology of Hbpathies in Europe
EHA Library, Fred Piel, 313429
Red cell transfusions: Current best practice and how to further optimize?
EHA Library, Marlijn Hoeks, 313430
ALL subtypes
EHA Library, Ilaria Iacobucci, 313431
Advances in risk stratification in pediatric acute lymphoblastic leukemia
EHA Library, Anthony Moorman, 313432
Novel agents for phase 3 trials
EHA Library, Michel Zwaan, 313433
New insights in the pathogenesis of autoimmune hemolytic diseases
EHA Library, Wilma Barcellini, 313434
Sickle cell disease as a chronic problem
EHA Library, Marianne de Montalambert, 313485
Management of post allogeneic HCT auto/alloimmune cytopenia
EHA Library, Andreas Holbro, 313436
Vulnerabilities of indolent lymphomas: The tumor and the microenvironment
EHA Library, Leticia Quintanilla de Fend, 313437
Building blocks to optimize CLL treatment
EHA Library, Thorsten Zenz, 313440
Genetic heterogeneity of congenital neutropenias
EHA Library, Karl Welte, 313444
New drugs and BMT: How to choose
EHA Library, Maria Domenica Cappellini, 313450
Primary mediastinal lymphoma
EHA Library, Maurizio Martelli, 313452
Testicular lymphoma
EHA Library, Annalisa Chiappella, 313453
Management of MM patients with high-risk disease
EHA Library, Jesús San Miguel, 313457
Immunotherapy and other novel immunological therapies
EHA Library, Daniel Olive, 313458
Natural Killer Cell-Mediated Immunosurveillance of leukemia
EHA Library, Yenan Bryceson, 313459
Basis of iron regulation for erythropoiesis
EHA Library, Laura Silvestri, 313461
Classification and clinical approach to atypical microcytic anemias
EHA Library, Patricia Aguilar Martinez, 313462
Eosinophilia
EHA Library, Andreas Reiter, 313466
Treatment of the older patient with AML
EHA Library, Courtney DiNardo, 313469
Inherited platelet disorders and mutations in hematopoietic transcription factors
EHA Library, A. Koneti Rao, 313473
Immune thrombocytopenia (ITP): New insights on pathophysiology
EHA Library, John Semple, 313474
TTP vs HUS - Novel insights
EHA Library, Marie Scully, 313475
Biological basis of transformation
EHA Library, Ulf Klein, 313476
Current treatment options for transformed disease
EHA Library, Silvia Montoto, 313477
Potentially druggable targets in transformed disease
EHA Library, Davide Rossi, 313478
Update on oral contraception and VTE
EHA Library, Marc Blondon, 313480
Niche contributions to bone marrow failure and clonal evolution in MDS
EHA Library, Marc Raaijmakers, 313482
The molecular basis of p53 mutations in MDS
EHA Library, Benjamin Ebert, 313483
RELATIVE FINANCIAL IMPLICATIONS OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN DEVELOPING AND THE DEVELOPED WORLD
EHA Library, Santanu Sen, 298412
COST-EFFECTIVENESS OF REFERRALS TO SECONDARY CARE FOR ELEVATED SERUM VITAMIN B12
EHA Library, Dipal Mehta, 298411
DIAGNOSIS OF ACUTE LEUKEMIA AND ITS IMPACT IN A RESOURCE POOR CENTRE OF EASTERN INDIA: A RETROSPECTIVE OVERVIEW
EHA Library, Debmalya Bhattacharyya, 298410
WHAT ARE THE CHALLENGES FOR BUILDING REAL WORLD COMPARATIVE COHORTS IN HAEMATOLOGY?
EHA Library, Nikita Jeswani, 298409
ESTABLISHMENT REFERENCE INTERVALS IN MALAYSIA : A PERFORMANCE EVALUATION AND COMPARISON OF HAEMATOLOGICAL PARAMETERS BETWEEN SYSMEX XE5000 AND XN3000
EHA Library, Siew Lian Chong, 298408
EXTENT OF HEMOGLOBIN GLYCATION ON THE BRINK BETWEEN HEMATOLOGY AND DIABETOLOGY
EHA Library, Urs Nydegger, 298407
PAST, PRESENT, FUTURE – THE ROLE OF EXTERNAL QUALITY ASSESSMENT PARTICIPATION IN ASSURING THE ACCURACY OF GENOMIC TESTING IN HAEMATOLOGICAL NEOPLASMS
EHA Library, Katrina Rack, 298406
LIFE OF CENTRAL VENOUS ACCESS DEVICE (CVAD) IN PATIENTS WITH HEMATOLOGIC DISORDERS – EXPERIENCE OF A SINGLE TERTIARY CARE CENTRE IN INDIA
EHA Library, Revanth Boddu, 298405
THE INFORMATION SEEKING BEHAVIOURS OF MYELOMA PATIENTS AND CARERS WHILST ENGAGING WITH THE MYELOMA UK INFOLINE HELPLINE AND THE ASK THE NURSE EMAIL SERVICES
EHA Library, Sandra Quinn, 298404
COMPARISON OF FOUR AUTOMATED HEMATOLOGY ANALYZERS; BECKMAN COULTER DXH 900, SYSMEX XP-300, ABBOTT CELL-DYN EMERALD AND HORIBA ABX PENTRA
EHA Library, Hyunji Choi, 298403
TYPE OF VENTILATORY SUPPORT AS AN INDEPENDENT PROGNOSTIC FACTOR IN CRITICALLY ILL HEMATOLOGIC MALIGNANCIES PATIENTS
EHA Library, Carolina Oliver, 298402

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings